mdmccradden.bsky.social
Bioethicist specializing in ethical and evidence-based integration of technologies in health care. AI Director, Women’s and Children’s Health Network | THRF Clinical Research Fellow, Australian Institute for Machine Learning. Adelaide, South Australia.
67 posts
573 followers
488 following
Regular Contributor
Active Commenter
comment in response to
post
100% endorse.
Might I suggest adding a point about the environmental cost of using GenAI?
comment in response to
post
It all happened because of our multi-disciplinary team 😊
Thank you to these legends! @istedman.bsky.social Azzy Assadi, Kelly Thai, Minfan Zhang, Fanny Chevalier, @shalmalijoshi.bsky.social , Sana Tonekaboni, and Anna Goldenberg
comment in response to
post
@istedman.bsky.social and I expand on the medicolegal context and alignment with this work here
www.sciencedirect.com/science/arti...
comment in response to
post
We also found surprising results, including that explanations are not critical, many fail to spot incorrect information in explanations, and automation bias can happen regardless of AI knowledge, experience, or domain expertise
comment in response to
post
Wtf?? Can’t wait to see how this turns out…
comment in response to
post
I wonder if it’s based on your geolocation? Mine still shows Gulf of Mexico (I’m in Australia)
comment in response to
post
comment in response to
post
For me it depends. If the goal is to convince the fence-sitters or ppl who might legitimately not know, I’ll do 2). But sometimes 3) when you just gotta get some stuff out there. No matter what, brings the receipts though - esp when saying something unpopular I try to let the facts do the talking
comment in response to
post
That dude made of bugs comes immediately to my mind… 😳
comment in response to
post
I really struggle with this 🙁 I try to tell myself that even if I have a small positive influence that’s a net benefit whereas leaving would remove that benefit so my suffering at least gives something small but good to the world 🤷🏼♀️
Your work is a HUGE positive and I’m grateful for it & you!
comment in response to
post
Sasha Luccioni I believe is the one who did the earliest and most realistic estimate of the impact of LLMs. She assembled an excellent resource here - huggingface.co/blog/sasha/a...
comment in response to
post
Huge thanks for the support from @aimlofficial.bsky.social and CIHR for their generous funding support!
comment in response to
post
Anton van der Vegt Mjaye Mazwi @karinv.bsky.social
comment in response to
post
Lesley-Anne Farmer Bobby Greer Anna Goldenberg Yvonne Ho @shalmalijoshi.bsky.social Jennie Louise Muhammad Mamdani Abdu Mohamud Lyle Palmer Antonios Peperidis Stephen Pfohl Mandy Rickard Carolyn Semmler @kdpsingh.bsky.social Devin Singh Seyi Soremekun @lanatikhomirov.bsky.social
comment in response to
post
Super grateful to our amazing steering team, our patient/consumer partners, our partners at the Aboriginal Health Unit at Women’s and Children’s. 🙏🏻
@unityofvirtue.bsky.social Judy Gichoya Mark Sendak Lauren Erdman @istedman.bsky.social Lauren Oakden-Rayner Ismail Akrout James Anderson
comment in response to
post
So reach out to me and @xiaoliu.bsky.social if you want to get involved with #CANAIRI to build the practices around translational trials for better AI translation!
comment in response to
post
We propose that ethical governance for health institutions should be grounded in these local evaluations (not just AI vibes 😎) to ensure that when we say a tool ‘works,’ it means it works for US, for OUR patients, for OUR staff, and we have the evidence to say that.
comment in response to
post
What does this look like?
It will be different for each tool, depending on many things including how much works has been done before on similar tools, how different the local context is, etc.
How do we decide? That’s what we want to figure out, and we need your help!
comment in response to
post
Fairness evaluations, human factors, cognitive science, patient engagement, environmental considerations (+++ to this one!), economics, and more ➡️ taking this global perspective from the get-go we think will reduce wasteful translation and optimize the benefit!
comment in response to
post
Many know this already. But we can be doing better with how silent trials are practiced. It’s not just about the model - so we introduce ‘translational trial’ to signal the need for a more holistic evaluation during this silent stage, recognizing that AI is a sociotechnical tool
comment in response to
post
Please give my regards to the resident trash pandas! 😍
comment in response to
post
Lol same!! And 2 of them I know because of my kids 😂
comment in response to
post
I feel this… sometimes just like
comment in response to
post
Me please! Clinical ethics and AI governance in healthcare 😊
comment in response to
post
Gary, do you have recommendations or knowledge of any resources or processes for the science review step for ethics (IRB/HREC) approvals? We’re using the reporting guidelines but it doesn’t get at the validity of the methods…
comment in response to
post
I read they said how excited they were to be able to eliminate those pesky and time-intensive “review cycles” 😂
sfist.com/2024/11/11/a...
comment in response to
post
Hi all! Clinical ethicist and researcher in novel tech in healthcare, paediatric ethics, research ethics. Canadian now in Australia! Would love to meet more folks on here :)
comment in response to
post
Finally, we got a great question from Italian attendees - practically speaking, what can we do?
My answer is local, sociotechnical evaluation, partnering with consumers 😁 Project CANAIRI with @DrXiaoLiu will aim to address this!
t.co/M0lfXQxsxI
comment in response to
post
Also highlighted issues of testimonial injustice as @danielbuchman.bsky.social Katrina Hui and I discussed in
t.co/MOwE6Hsakc